我院2009-2011年中药注射剂应用分析  

Analysis of the Utilization of TCM Injection in Our Hospital during 2009-2011

作　　者：刘昌叶[1] 王杰松[1] 王欢[1] 张捷[1] 

机构地区：[1]解放军第306医院药学部,北京100101

出　　处：《中国药房》2013年第7期649-651,共3页China Pharmacy

摘　　要：目的:了解我院中药注射剂的使用情况,分析其临床应用的合理性,指导临床合理用药。方法:采集我院药库2009-2011年中药注射剂相关信息,采用金额排序法、用药频度(DDDs)排序法、日均费用(DDC)和排序比进行统计分析。结果:我院2009-2011年中药注射剂的年销售金额分别是1160.40、1526.93、1692.73万元,2010年增幅31.59%,2011年增幅10.86%。3年内,中药注射剂年销售金额占当年全部中成药总销售金额的份额维持在30%左右,抗肿瘤药年销售金额增幅最大,接近8%。消癌平注射液年销售金额3年均排名第1,分别是212.34、296.33、369.34万元。DDDs较大的主要是活血类中药注射剂;而抗肿瘤药则相反。结论:我院中药注射剂临床应用总体较合理,但抗肿瘤类需要适当控制使用。OBJECTIVE： To summarize the utilization of TCM injection in our hospital, and analyze the rationality of clinical application, and provide guidance for rational use of drugs. METHODS ： All data of TCM injection of our hospital during 2009-- 2011 was collected, sorted by consumption sum, DDDs, DDC and sorting ratio. RESULTS： The amounts of TCM injection in our hospital during 2009--2011 were 1 160.40, 1 526.93 and 1 692.73 million yuan, increasing by 31.59% in 2010 and 10.86%in 2011. The consumption sum of TCM injection always accounted for 30% of total consumption sum of Chinese patent medicine in 3 years. The growth rate of anti-tumor agents was the fastest, nearing to 8 %. The consumption sum of Xiao＇aiping injection occupied the first place in 3 years, and the amount of it was 212.34, 296.33 and 369.34 million yuan, respectively. TCM injection for acti- vating blood took up the front place in the list of DDDs ; the opposite was anti-tumor agents. CONCLUSION： The use of TCM in- jections in our hospital is generally rational, but anti-tumor agent should be appropriately restrained.

关 键 词：中药注射剂 用药分析 合理用药 

分 类 号：R97[医药卫生—药品] R286[医药卫生—药学]